NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
์ข
๋ชฉ ์ฝ๋ NBY
ํ์ฌ ์ด๋ฆNovaBay Pharmaceuticals Inc
์์ฅ์ผOct 26, 2007
CEOKazley (Michael John)
์ง์ ์14
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃOct 26
์ฃผ์2000 Powell St Ste 1150
๋์EMERYVILLE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX โ NASDAQ Basic Amex
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ94608-1804
์ ํ15108998800
์น์ฌ์ดํธhttps://novabay.com/
์ข
๋ชฉ ์ฝ๋ NBY
์์ฅ์ผOct 26, 2007
CEOKazley (Michael John)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์